- Home
- BIDU vs INM Comparison
BIDU vs INM Comparison
Compare BIDU & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIDU
- INM
- Stock Information
- Founded
- BIDU 2000
- INM 1981
- Country
- BIDU China
- INM Canada
- Employees
- BIDU N/A
- INM N/A
- Industry
- BIDU Computer Software: Programming Data Processing
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- BIDU Technology
- INM Health Care
- Exchange
- BIDU Nasdaq
- INM Nasdaq
- Market Cap
- BIDU 43.2B
- INM 5.1M
- IPO Year
- BIDU 2005
- INM N/A
- Fundamental
- Price
- BIDU $121.08
- INM $2.12
- Analyst Decision
- BIDU Strong Buy
- INM
- Analyst Count
- BIDU 10
- INM 0
- Target Price
- BIDU $128.90
- INM N/A
- AVG Volume (30 Days)
- BIDU 6.4M
- INM 125.1K
- Earning Date
- BIDU 11-20-2025
- INM 11-13-2025
- Dividend Yield
- BIDU N/A
- INM N/A
- EPS Growth
- BIDU 41.81
- INM N/A
- EPS
- BIDU 10.88
- INM N/A
- Revenue
- BIDU $18,544,068,789.00
- INM $4,942,633.00
- Revenue This Year
- BIDU N/A
- INM N/A
- Revenue Next Year
- BIDU $4.76
- INM N/A
- P/E Ratio
- BIDU $11.18
- INM N/A
- Revenue Growth
- BIDU N/A
- INM 7.50
- 52 Week Low
- BIDU $74.71
- INM $1.72
- 52 Week High
- BIDU $149.51
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- BIDU 46.92
- INM 43.11
- Support Level
- BIDU $119.10
- INM $2.04
- Resistance Level
- BIDU $123.71
- INM $2.24
- Average True Range (ATR)
- BIDU 5.25
- INM 0.14
- MACD
- BIDU -3.59
- INM -0.01
- Stochastic Oscillator
- BIDU 5.10
- INM 16.31
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 70% of core revenue from online marketing services from its search engine in 2024. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.